Welcome to the Cellular Revolution with SpectraCell

Based in Houston, Texas, SpectraCell Laboratories was founded with the vision of pioneering a new paradigm in diagnostic testing, focusing on truly personalized solutions. We acquired the rights to the exclusive license for a new technology developed by the Clayton Foundation at the University of Texas.

SpectraCell commenced operations to commercialize a unique, proprietary live blood analysis called MicroNutrient Test (MNT) measuring functional intracellular micronutrient deficiencies of 31 vitamins, minerals, amino acids, and antioxidants.  This test also reflects an individual's metabolic processes, Total Antioxidant Function (Spectrox®) and Total Immune Function (Immunidex).

Our company emphasizes the importance of biochemical individuality and the role of subclinical deficiencies in chronic diseases, which drives our unique and innovative solutions.

SpectraCell became the first and only lab, still to this day, to offer the Lipoprotein Particle Profile, (LPP®) providing an advanced assessment of cardiovascular risk using patented ultracentrifugation technology, developed at Texas A&M University, that goes well beyond the standard cholesterol test and lipid panel.

We Continue to expand specialized offerings in cardiovascular health and genetic predisposition.

We became the first to commercialize the Telomere Test, utilizing whole blood to measure the length of telomeres and provide insights into cellular aging as a comparison of biological age to chronological age.

We expand testing services to include Comprehensive Cardiometabolic Testing, offering a deeper understanding of metabolic and cardiovascular health.

SpectraCell introduces MTHFR Genetic Testing, providing insights into genetic predispositions affecting methylation and overall health.

SpectraCell continues to develop and introduce innovative solutions in the emerging field of personalized functional medicine and chronic disease management.

In Q1, SpectraCell adds a range of Wellness panels including Mental Health, Immune Health, Energy Optimization, and Weight Optimization.

In Q2, we add Cardiac Nexus, Age Nexus, and Cardi-A1c tests to our Wellness portfolio further enhancing the ability to provide comprehensive health assessments.

We are expanding our Provider Network beyond 14 countries across North, Central, and South America, Europe, and the Middle East to encompass Southeast Asia. Our innovation will persist as we collaborate with our team of scientists, practitioners, and thought leaders to delve into specialized Lifestyle Medicine programs, nutritional supplement solutions and regenerative stem cell therapies. Motivated by a common goal to expedite precision medicine and disrupt the future of healthcare, we will persistently innovate and maintain our leadership in personalized diagnostic testing, improving the comprehension and management of individual health needs.